Blog
GLP-1 prescriptions remained elevated three months after Medicare GLP-1 Bridge launch
Understanding the real-world burden of ornithine transcarbamylase deficiency (OTCD): New insights into a rare disease
AMCP Nexus: Early uptake of oral semaglutide for obesity (Wegovy pill)
Truveta Genome Project: The next chapter in Saving Lives with Data
CGM use associated with lower risk of death and cardiovascular events in adults with type 2 diabetes
CGM use in adults with type 2 diabetes on basal insulin was linked to 44% lower risk of death and fewer heart attacks and strokes in…
Learning together is healthcare’s greatest innovation
Truveta recognized as LinkedIn Top Startup in Seattle
